Biotech Late Stage Investors & VC Firms
360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
500 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
222 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$100K – $50M
157 people
Lightspeed Venture Partners
Menlo ParkSeed–Late Stage$1M – $5M
115 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
81 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
126 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
185 people
RA Capital
BostonSeed–Late Stage
278 people
Bain Capital
BostonPre-Seed–Late Stage
290 people
Transpose Platform Management
San FranciscoPre-Seed–Late Stage
23 people
Valor Equity Partners
ChicagoSeed–Late Stage
127 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
55 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
187 people
Hercules Capital, Inc.
San MateoSeed–Late Stage
52 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
33 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
99 people
Deerfield Management Company
New YorkSeed–Late Stage
144 people
Saints Capital
DenverGrowth–Late Stage
22 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
69 people
Wellington Management
BostonGrowth–Late Stage$5M – $50M
84 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Frazier Healthcare Partners
SeattleGrowth–Late Stage$50M – $400M
103 people
Frequently asked questions
- Who are the top biotech late stage investors & vc firms?
- Top biotech late stage investors & vc firms include Alumni Ventures, General Atlantic, General Catalyst, Sequoia Capital, Lightspeed Venture Partners, New Enterprise Associates (NEA), GV (Google Ventures), Norwest Venture Partners — 360 firms in total meet the criteria.
- What is the typical first check among biotech late stage investors & vc firms?
- The median first check among the 360 biotech late stage investors & vc firms tracked here is $1M.
- How many biotech late stage investors & vc firms lead rounds?
- 82 of the 360 biotech late stage investors & vc firms tracked here lead investment rounds.
Related lists
Biotech Investors & VC Firms (2585)Biotech Seed Investors & VC Firms (2105)Late Stage Investors & VC Firms (1710)Biotech Series A Investors & VC Firms (1693)Biotech Investors & VC Firms in North America (1688)Biotech Investors & VC Firms in United States (1535)Biotech Investors & VC Firms in Europe (990)Biotech Pre-Seed Investors & VC Firms (987)Late Stage Investors & VC Firms in North America (915)Biotech Investors & VC Firms in Global (887)
Data sourced from public filings and firms' own websites — see our methodology.









.png)




































































.jpeg)































